Metabiomed Co Ltd
KOSDAQ:059210
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
M
|
Metabiomed Co Ltd
KOSDAQ:059210
|
149.7B KRW |
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
65.2B USD |
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
9.8T JPY |
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
31.8B CHF |
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
111.4B DKK |
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.4B USD |
Loading...
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.2B GBP |
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6.5B USD |
Loading...
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
41.1B CNY |
Loading...
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
833.6B JPY |
Loading...
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
4.8B USD |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
Metabiomed Co Ltd
Glance View
Meta Biomed Co., Ltd. engages in the manufacture and sale of surgical and other medical devices. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2008-04-15. The firm mainly operates its business through three divisions: suture material division, dental division and bone material division. Its suture material division provides suture materials, such as polyglycolic acid (PGA) synthetic absorbable braids, polyglycolic acid-co-lactic acid (PGLA) absorbable braids, polydioxanone (PDO) synthetic absorbable monofilaments, polyglycolide-co-epsilon-caprolactone (PGCL) synthetic absorbable monofilaments and others. Its dental division provides dental materials and equipment, such as gutta percha cordless obturation systems, electronic apex locators, taper points, root canal sealers, root canal filling materials and others. Its bone materials division provides bone graft substitutes. The company also distributes dental-related products.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Metabiomed Co Ltd is 23%, which is below its 3-year median of 35.2%.
Over the last 3 years, Metabiomed Co Ltd’s Gross Margin has decreased from 43.4% to 23%. During this period, it reached a low of 9.8% on Dec 31, 2023 and a high of 47.4% on Mar 31, 2024.
